Home › Hidradenitis Suppurativa › Minnesota
Hidradenitis Suppurativa clinical trials in Minnesota
4 studies for Hidradenitis Suppurativa are looking for participants at sites in Minnesota.
Cities in Minnesota
ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa
- Oruka Therapeutics Investigative Site, New Brighton
RecruitingPhase 2
Ages 18 to 79 · All sexes · Updated Sep 24, 2026 · NCT07783542Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
- Investigative Site US011, Minneapolis
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT06855498Capsule Microbiota Transplant Therapy for Hidradenitis Suppurativa
- University of Minnesota, Minneapolis
RecruitingEarly phase 1
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT06058520A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic
- University of Minnesota, Minneapolis
RecruitingObservational study
Ages 18 to 71 · All sexes · Updated Apr 16, 2026 · NCT07123038From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.